Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €0.09 EUR
Change Today +0.012 / 15.38%
Volume 0.0
2GD On Other Exchanges
As of 2:39 AM 07/30/15 All times are local (Market data is delayed by at least 15 minutes).

gi dynamics inc-cdi (2GD) Snapshot

Previous Close
Day High
Day Low
52 Week High
09/17/14 - €0.39
52 Week Low
05/13/15 - €0.06
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for GI DYNAMICS INC-CDI (2GD)

Related News

No related news articles were found.

gi dynamics inc-cdi (2GD) Related Businessweek News

No Related Businessweek News Found

gi dynamics inc-cdi (2GD) Details

GI Dynamics, Inc. designs, develops, and markets medical devices for non-surgical approaches. The company’s lead product includes EndoBarrier, an incision-free, non-anatomy altering solution designed to mimic the duodenal-jejunal exclusion created by gastric bypass surgery. It serves health care providers, such as gastroenterologists, endocrinologists, and bariatric surgeons; and distributors of medical devices. The company sells its product directly, as well as through local and regional distributors in Europe, South America, the Asia Pacific region, and the Middle East. GI Dynamics, Inc. was founded in 2003 and is headquartered in Lexington, Massachusetts.

69 Employees
Last Reported Date: 03/30/15
Founded in 2003

gi dynamics inc-cdi (2GD) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $128.1K
Compensation as of Fiscal Year 2014.

gi dynamics inc-cdi (2GD) Key Developments

GI Dynamics, Inc. Announces Departure of David Maggs as Chief Medical Officer

GI Dynamics, Inc. announced that on 18 June 2015, the company terminated the employment of David Maggs, M.D., for cause, effective as of June 18, 2015. Dr. Maggs remains subject to a Nondisclosure, Nonsolicitation and Noncompete Agreement with the company.

GI Dynamics, Inc. Announces New Data Presented at ADA Demonstrate Early Effect of EndoBarrier Therapy on Glucose Control and Bile Acid Regulators

GI Dynamics, Inc. announced new data showing the effect of EndoBarrier® Therapy on bile acid regulators and other anthropometric, biochemical and hormonal parameters. Professor Martin Haluzik of the IKEM Research Centre Prague, Czech Republic, presented these findings during an oral session at the 75th Annual Meeting of the American Diabetes Association in Boston, Massachusetts. Prof. Haluzik’s presentation, titled ‘Ten Months of Treatment with Endoscopic Duodenal-jejunal Bypass Liner Reduces Glycemic Variability, Increases Serum Fibroblast Growth Factor 19 (FGF-19), and Partially Restores the Incretin Effect in Obese Subjects with Type 2 Diabetes Mellitus,’ follows the progress of 30 obese patients with type 2 diabetes after being implanted with the EndoBarrier gastrointestinal liner. Study results show that EndoBarrier Therapy led to an improvement in multiple glycemic parameters and a sustained decrease in body weight and body fat. Notably, fibroblast growth factor 19 (FGF-19), a potent regulator of bile acid, glucose and fat metabolism, was markedly increased by EndoBarrier Therapy. In addition, EndoBarrier Therapy also raised levels of the incretin hormone GLP-1.

GI Dynamics, Inc. - Shareholder/Analyst Call

GI Dynamics, Inc. - Shareholder/Analyst Call


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
2GD:GR €0.09 EUR +0.012

2GD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 2GD.
View Industry Companies

Industry Analysis


Industry Average

Valuation 2GD Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 18.9x
Price/Book 1.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales 3.0x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GI DYNAMICS INC-CDI, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at